While you may not be familiar with canine separation anxiety, you are probably
familiar with its symptoms. While you are gone, your dog may do one or several
of the following:
- Chew destructively
- Bark or whine
- Inappropriate urination and/or defecation
- Drool
- Pace
- Tremble
- Vomit
- … or worse
Separation anxiety is a clinical condition in your dog's brain. Your
pet is not a bad dog. Your pet's behavior is the result of separation
anxiety.
Reconcile® is a once-daily, chewable, flavored tablet for the
treatment of separation anxiety in conjunction with a behavior modification
plan.
Reconcile®, approved by the FDA, helps manage separation anxiety and improves your pet's receptivity
to a simple training plan also called behavior modification. The four-step
BOND™ training plan focuses on reinforcing positive behavior.
Reconcile® and the BOND™ training plan form a logical, easy-to-follow
program that makes it possible for you to treat and manage separation anxiety
and restore a happy, healthy relationship with your pet.
Important Safety Information
- The most common adverse reactions recorded during clinical trials with Reconcile® were calm or lethargy, reduced appetite, vomiting, shaking, diarrhea, restlessness, excessive vocalization, aggression, and, in infrequent cases, seizures.
- Reconcile® chewable tablets are contraindicated for dogs with epilepsy or a history of seizures; with drugs that lower the seizure threshold; with a monoamine oxidase inhibitor (MAOI) or within a minimum of 14 days of discontinuing therapy with an MAOI; in dogs with a known hypersensitivity to fluoxetine HCl or other SSRIs.
- A six week washout interval should be observed following discontinuation of therapy with Reconcile® chewable tablets prior to the administration of any drug that may adversely interact with fluoxetine or norfluoxetine.
- For full product label, including complete safety information, click here.
